Development of Novel Biomarkers to Predict REHOSPitalization in Chronic Heart Failure

Development of Novel Biomarkers to Predict REHOSPitalization in Chronic Heart Failure - PREHOSP-CHF Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000021657

Enrollment

1050

Registered

2016-04-01

Start date

2014-12-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic heart failure

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients admitted for acute heart failure who discharge alive from hospital

Exclusion criteria

Exclusion criteria: 1. Patients with acute coronary syndrome within 14 days 2. Patients who plan to undergo elective revascularization, cardiac surgery, or implantable cardiac device therapy after discharge. 3. Malignancy 4. Inflammatory disease 5. Patients with low drug compliance 6. Inability to give written informed consent 7. Under 20 years old 8. Not eligible in the investigator's opinion

Design outcomes

Primary

Measure	Time frame
Cardiovascular death and re-hospitalization for heart failure	—

Secondary

Measure	Time frame
All-cause death Major adverse cardiovascular events Cardiovascular death Re-hospitalization for heart failure All-cause re-hospitalization	—

Countries

Japan

Contacts

Public ContactHiromichi Wada

National Hospital Organization Kyoto Medical Center Division of Translational Disease

hwada@kuhp.kyoto-u.ac.jp075-641-9161

Outcome results